OAC

OMERS Administration Corp Portfolio holdings

AUM $14B
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+24.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14B
AUM Growth
+$1.23B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,235
New
Increased
Reduced
Closed

Top Buys

1 +$160M
2 +$156M
3 +$155M
4
DUK icon
Duke Energy
DUK
+$108M
5
CVX icon
Chevron
CVX
+$108M

Top Sells

1 +$126M
2 +$117M
3 +$105M
4
HES
Hess
HES
+$105M
5
XOM icon
Exxon Mobil
XOM
+$104M

Sector Composition

1 Technology 27.59%
2 Financials 18.93%
3 Industrials 9.88%
4 Consumer Discretionary 9%
5 Healthcare 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPC
1201
Ridgepost Capital
RPC
$873M
-11,500
RCAT icon
1202
Red Cat Holdings
RCAT
$1.8B
-44,500
RUMBW
1203
Rumble Inc Warrant
RUMBW
$410M
-25,000
SAGE
1204
DELISTED
Sage Therapeutics
SAGE
-424,300
SATL icon
1205
Satellogic
SATL
$457M
-23,200
SKWD icon
1206
Skyward Specialty Insurance
SKWD
$2.17B
-4,600
SKX
1207
DELISTED
Skechers
SKX
-79,200
SN icon
1208
SharkNinja
SN
$16.1B
-6,200
STKL
1209
SunOpta
STKL
$762M
-13,900
SWTX
1210
DELISTED
SpringWorks Therapeutics
SWTX
-53,300
TDUP icon
1211
ThredUp
TDUP
$468M
-24,400
THRD
1212
DELISTED
Third Harmonic Bio
THRD
-426,900
TRVI icon
1213
Trevi Therapeutics
TRVI
$1.68B
-35,000
TSHA icon
1214
Taysha Gene Therapies
TSHA
$1.23B
-72,900
USFD icon
1215
US Foods
USFD
$20.3B
-19,400
VERV
1216
DELISTED
Verve Therapeutics
VERV
-371,200
VIGL
1217
DELISTED
Vigil Neuroscience
VIGL
-128,500
WLDN icon
1218
Willdan Group
WLDN
$1.22B
-14,400
WLK icon
1219
Westlake Corp
WLK
$13.5B
-11,380
CTRI icon
1220
Centuri Holdings
CTRI
$2.97B
-14,500
RBRK icon
1221
Rubrik
RBRK
$11.2B
-7,900
VIK icon
1222
Viking Holdings
VIK
$32B
-15,500
ATYR
1223
aTyr Pharma
ATYR
$88.4M
-31,800
CGBSW
1224
DELISTED
Crown LNG Holdings Limited Warrants
CGBSW
-33,333
NPKI
1225
NPK International
NPKI
$1.17B
-11,200